ketoconazole has been researched along with Infant, Premature, Diseases in 9 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A neonate who developed systemic candidiasis was successfully treated with oral ketoconazole (Nizoral; Janssen) and flucytosine (Alcobon; Roche)." | 7.67 | Oral ketoconazole and flucytosine for neonatal systemic candidiasis. ( Cotton, MF; Ransome, OJ, 1989) |
| "A neonate who developed systemic candidiasis was successfully treated with oral ketoconazole (Nizoral; Janssen) and flucytosine (Alcobon; Roche)." | 3.67 | Oral ketoconazole and flucytosine for neonatal systemic candidiasis. ( Cotton, MF; Ransome, OJ, 1989) |
| "Amphotericin B at lower maintenance dose, together with 5 flucytosine (5FC), are the preferred drugs for treatment of systemic candidiasis at present." | 1.27 | Systemic candidiasis in premature infants experience with drug treatment. ( Ho, NK, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van den Anker, JN | 1 |
| van Lingen, RA | 1 |
| Koster, M | 1 |
| Heykants, J | 1 |
| Sauer, PJ | 1 |
| Mazor, M | 1 |
| Chaim, W | 1 |
| Shinwell, ES | 1 |
| Glezerman, M | 1 |
| Bhandari, V | 1 |
| Narang, A | 1 |
| Barzilai, A | 1 |
| Sperling, RS | 1 |
| Hyatt, AC | 1 |
| Wedgwood, JF | 1 |
| Reidenberg, BE | 1 |
| Hodes, DS | 1 |
| Handrick, W | 1 |
| Schönborn, C | 1 |
| Spencker, FB | 1 |
| Hückel, D | 1 |
| Cotton, MF | 1 |
| Ransome, OJ | 1 |
| Vargas-Origel, A | 1 |
| Rodríguez-Cámara, A | 1 |
| Aldana-Valenzuela, C | 1 |
| Manjarrez-Gutiérrez, G | 1 |
| Abdo-Bassol, F | 1 |
| Seeliger, HP | 1 |
| Ho, NK | 1 |
9 other studies available for ketoconazole and Infant, Premature, Diseases
| Article | Year |
|---|---|
Insufficient ketoconazole concentrations in preterm infants with fungal infections.
Topics: Candidiasis; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Infant, Prematur | 1993 |
Asymptomatic amniotic fluid invasion with Candida albicans in preterm premature rupture of membranes. Implications for obstetric and neonatal management.
Topics: Adult; Amniotic Fluid; Amphotericin B; Candida albicans; Candidiasis; Chorioamnionitis; Female; Feta | 1993 |
Oral itraconazole therapy for disseminated candidiasis in low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature, Di | 1992 |
Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
Topics: Acyclovir; Adult; Diseases in Twins; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Human | 1990 |
[Infections caused by Candida krusei in newborn infants].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, New | 1989 |
Oral ketoconazole and flucytosine for neonatal systemic candidiasis.
Topics: Administration, Oral; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; | 1989 |
[Systemic candidiasis].
Topics: Amphotericin B; Candidiasis; Combined Modality Therapy; Female; Gestational Age; Humans; Infant; Inf | 1985 |
[Prevention of mycoses caused by yeasts].
Topics: Candidiasis; Cryptococcosis; Disinfection; Humans; Infant; Infant, Newborn; Infant, Premature, Disea | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newbo | 1985 |